Olmesartan CAS: 144689-24-7 Chaw Tsim Khoom

Olmesartan medoxomil, phenyl]phenyl]methyl]imidazole-4-carboxylate (Benicar, Olmetec) siv lub kaw lus tetrazolering ua nws lub kaw lus acidic, uas koom nrog hauv kev khi receptor. Thaum muab rau tus neeg mob, cov tshuaj sai thiab tag nrho bioactivated los ntawm ester hydrolysis ntawm medoxomil thaum lub sijhawm nqus los ntawm txoj hnyuv plab. Olmesartan yog biphenylyltetrazole. Nws muaj lub luag haujlwm ua tus neeg sawv cev tiv thaiv ntshav siab thiab angiotensin receptor antagonist.

Txiav txim los yog Thov Kev Hais Nqe

Cov Lus Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Omesartan yog ib qho tshuaj AT2 antagonist uas zoo thiab xaiv tau. Omesartan axetil muaj cov nyhuv txo qhov ntshav siab heev. Tom qab noj, nws raug deesterified tag nrho hauv phab ntsa plab hnyuv me thiab hloov mus ua cov metabolite Olmesartan uas nquag siv. Olmesartan yog ib qho tshuaj chemically selective non peptide angiotensin II receptor antagonist uas xaiv thaiv qhov kev khi ntawm angiotensin II rau cov leeg nqaij du AT1 receptors, yog li thaiv qhov vasoconstrictive effect ntawm angiotensin II.

Qauv Khoom

Khoom Ntim:

Cov Lus Qhia Ntxiv:

Kev sau ua ke	C30H32N6O6
Kev Ntsuas	99%
Qhov tsos	Hmoov dawb
CAS Nr.	144689-24-7
Ntim khoom	25KG
Lub Neej Txee	2 xyoos
Kev Khaws Cia	Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj	ISO.